Scholar Rock Holding Corp 8-K

What Happened
On January 12, 2026, Scholar Rock Holding Corporation filed an 8-K to announce a business update and to report a preliminary, unaudited estimate of its cash, cash equivalents and marketable securities of approximately $365 million as of December 31, 2025. The company furnished a press release (Exhibit 99.1) and a corporate presentation/slides for the 44th Annual J.P. Morgan Healthcare Conference (Exhibit 99.2) and said it will be meeting with conference participants the week of January 12, 2026. The consolidated year‑end audit is ongoing and the company cautioned the preliminary amount could change.

Key Details

• Estimated cash, cash equivalents and marketable securities: approximately $365 million (unaudited) as of December 31, 2025.
• Filing date: January 12, 2026; press release = Exhibit 99.1; corporate presentation/slides = Exhibit 99.2.
• The year-end audit is ongoing; the preliminary financial information does not constitute final audited results and may change.
• The 8-K includes forward‑looking statements covering expectations (e.g., clinical and commercial timing, potential cash runway into 2027) and standard risk disclaimers.

Why It Matters
For investors, the preliminary $365M cash balance provides an indication of Scholar Rock’s near‑term financial resources and potential runway to fund its clinical and development programs. However, because the figure is unaudited and subject to change upon completion of the company’s year‑end audit, it should be treated as provisional. The furnished press release and JPM presentation give investors additional detail on 2026 strategic priorities and upcoming milestones, while the filing’s forward‑looking statements and risk disclosures remind investors these plans are subject to uncertainty.